The Lancet Oncology

Công bố khoa học tiêu biểu

* Dữ liệu chỉ mang tính chất tham khảo

Sắp xếp:  
Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future
The Lancet Oncology - Tập 21 - Trang e135-e145 - 2020
Eric S Christenson, Elizabeth Jaffee, Nilofer S Azad
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
The Lancet Oncology - Tập 14 - Trang 257-264 - 2013
Robert Haddad, Anne O'Neill, Guilherme Rabinowits, Roy Tishler, Fadlo Khuri, Douglas Adkins, Joseph Clark, Nicholas Sarlis, Jochen Lorch, Jonathan J Beitler, Sewanti Limaye, Sarah Riley, Marshall Posner
Do β-tubulin mutations have a role in resistance to chemotherapy?
The Lancet Oncology - Tập 5 - Trang 158-164 - 2004
Helen K Berrieman, Michael J Lind, Lynn Cawkwell
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA study): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 study
The Lancet Oncology - Tập 14 - Trang 461-471 - 2013
Sandra M Swain, Sung-Bae Kim, Javier Cortés, Jungsil Ro, Vladimir Semiglazov, Mario Campone, Eva Ciruelos, Jean-Marc Ferrero, Andreas Schneeweiss, Adam Knott, Emma Clark, Graham Ross, Mark C Benyunes, José Baselga
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial
The Lancet Oncology - Tập 13 - Trang 679-687 - 2012
Claus Rödel, Torsten Liersch, Heinz Becker, Rainer Fietkau, Werner Hohenberger, Torsten Hothorn, Ullrich Graeven, Dirk Arnold, Marga Lang-Welzenbach, Hans-Rudolf Raab, Heiko Sülberg, Christian Wittekind, Sergej Potapov, Ludger Staib, Clemens Hess, Karin Weigang-Köhler, Gerhard G Grabenbauer, Hans Hoffmanns, Fritz Lindemann, Anke Schlenska-Lange
Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study
The Lancet Oncology - Tập 19 - Trang 1654-1667 - 2018
Benjamin J Solomon, Benjamin Besse, Todd M Bauer, Enriqueta Felip, Ross A Soo, D Ross Camidge, Rita Chiari, Alessandra Bearz, Chia-Chi Lin, Shirish M Gadgeel, Gregory J Riely, Eng Huat Tan, Takashi Seto, Leonard P James, Jill S Clancy, Antonello Abbattista, Jean-François Martini, Joseph Chen, Gerson Peltz, Holger Thurm
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
The Lancet Oncology - Tập 19 - Trang 521-536 - 2018
Marina Chiara Garassino, Byoung-Chul Cho, Joo-Hang Kim, Julien Mazières, Johan Vansteenkiste, Hervé Lena, Jesus Corral Jaime, Jhanelle E Gray, John Powderly, Christos Chouaid, Paolo Bidoli, Paul Wheatley-Price, Keunchil Park, Ross A Soo, Yifan Huang, Catherine Wadsworth, Phillip A Dennis, Naiyer A Rizvi
Knowledge, attitudes, and behaviours towards cancer screening in indigenous populations: a systematic review
The Lancet Oncology - Tập 15 - Trang e504-e516 - 2014
Fariba Kolahdooz, Se Lim Jang, André Corriveau, Carolyn Gotay, Nora Johnston, Sangita Sharma
Preventive therapy for cancer
The Lancet Oncology - Tập 18 - Trang e472-e482 - 2017
Jack Cuzick
Treatment approaches for EGFR-inhibitor-resistant patients with non-small-cell lung cancer
The Lancet Oncology - Tập 16 - Trang e447-e459 - 2015
Chee-Seng Tan, David Gilligan, Simon Pacey
Tổng số: 1,581   
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 10